메뉴 건너뛰기




Volumn 2012, Issue , 2012, Pages

Antibody-dependent cellular cytotoxicity and nk cell-driven immune escape in HIV infection: Implications for HIV vaccine development

Author keywords

[No Author keywords available]

Indexed keywords

HARNESS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84871434642     PISSN: 16878639     EISSN: 16878647     Source Type: Journal    
DOI: 10.1155/2012/637208     Document Type: Review
Times cited : (19)

References (85)
  • 1
    • 48449090498 scopus 로고    scopus 로고
    • The aftermath of the Merck's HIV vaccine trial
    • 2-s2.0-48449090498 10.1186/1742-4690-5-56
    • Iaccino E., Schiavone M., Fiume G., Quinto I., Scala G., The aftermath of the Merck's HIV vaccine trial. Retrovirology 2008 5, article 56 2-s2.0-48449090498 10.1186/1742-4690-5-56
    • (2008) Retrovirology , vol.556
    • Iaccino, E.1    Schiavone, M.2    Fiume, G.3    Quinto, I.4    Scala, G.5
  • 2
    • 77955517683 scopus 로고    scopus 로고
    • HIV vaccines: Lessons learned and the way forward
    • 2-s2.0-77955517683 10.1097/COH.0b013e32833d17ac
    • Kim J. H., Rerks-Ngarm S., Excler J. L., Michael N. L., HIV vaccines: lessons learned and the way forward. Current Opinion in HIV and AIDS 2010 5 5 428 434 2-s2.0-77955517683 10.1097/COH.0b013e32833d17ac
    • (2010) Current Opinion in HIV and AIDS , vol.5 , Issue.5 , pp. 428-434
    • Kim, J.H.1    Rerks-Ngarm, S.2    Excler, J.L.3    Michael, N.L.4
  • 3
    • 77949833920 scopus 로고    scopus 로고
    • Is an HIV vaccine possible?
    • 2-s2.0-77949833920 10.1590/S1413-86702009000400013
    • Wilson N. A., Watkins D. I., Is an HIV vaccine possible? Brazilian Journal of Infectious Diseases 2009 13 4 304 310 2-s2.0-77949833920 10.1590/S1413-86702009000400013
    • (2009) Brazilian Journal of Infectious Diseases , vol.13 , Issue.4 , pp. 304-310
    • Wilson, N.A.1    Watkins, D.I.2
  • 6
    • 70349303282 scopus 로고    scopus 로고
    • The remarkable frequency of human immunodeficiency virus type 1 genetic recombination
    • 2-s2.0-70349303282 10.1128/MMBR.00012-09
    • Onafuwa-Nuga A., Telesnitsky A., The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiology and Molecular Biology Reviews 2009 73 3 451 480 2-s2.0-70349303282 10.1128/MMBR.00012-09
    • (2009) Microbiology and Molecular Biology Reviews , vol.73 , Issue.3 , pp. 451-480
    • Onafuwa-Nuga, A.1    Telesnitsky, A.2
  • 13
    • 43549111619 scopus 로고    scopus 로고
    • Crippling HIV one mutation at a time
    • DOI 10.1084/jem.20080569
    • Allen T. M., Altfeld M., Crippling HIV one mutation at a time. Journal of Experimental Medicine 2008 205 5 1003 1007 2-s2.0-43549111619 10.1084/jem.20080569 (Pubitemid 351679676)
    • (2008) Journal of Experimental Medicine , vol.205 , Issue.5 , pp. 1003-1007
    • Allen, T.M.1    Altfeld, M.2
  • 14
    • 20344389003 scopus 로고    scopus 로고
    • Reversion of immune escape HIV variants upon transmission: Insights into effective viral immunity
    • DOI 10.1016/j.tim.2005.03.011, PII S0966842X05000818
    • Kent S. J., Fernandez C. S., Dale C. J., Davenport M. P., Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity. Trends in Microbiology 2005 13 6 243 246 2-s2.0-20344389003 10.1016/j.tim.2005.03.011 (Pubitemid 40779808)
    • (2005) Trends in Microbiology , vol.13 , Issue.6 , pp. 243-246
    • Kent, S.J.1    Fernandez, C.S.2    Dale, C.J.3    Davenport, M.P.4
  • 18
    • 62749173126 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals
    • 2-s2.0-62749173126 10.1128/JVI.01960-08
    • Kearney M., Maldarelli F., Shao W., Margolick J. B., Daar E. S., Mellors J. W., Rao V., Coffin J. M., Palmer S., Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals. Journal of Virology 2009 83 6 2715 2727 2-s2.0-62749173126 10.1128/JVI.01960-08
    • (2009) Journal of Virology , vol.83 , Issue.6 , pp. 2715-2727
    • Kearney, M.1    Maldarelli, F.2    Shao, W.3    Margolick, J.B.4    Daar, E.S.5    Mellors, J.W.6    Rao, V.7    Coffin, J.M.8    Palmer, S.9
  • 19
    • 33845756711 scopus 로고    scopus 로고
    • Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution
    • DOI 10.1128/JVI.01231-06
    • Li B., Gladden A. D., Altfeld M., Kaldor J. M., Cooper D. A., Kelleher A. D., Allen T. M., Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. Journal of Virology 2007 81 1 193 201 2-s2.0-33845756711 10.1128/JVI.01231-06 (Pubitemid 44975160)
    • (2007) Journal of Virology , vol.81 , Issue.1 , pp. 193-201
    • Li, B.1    Gladden, A.D.2    Altfeld, M.3    Kaldor, J.M.4    Cooper, D.A.5    Kelleher, A.D.6    Allen, T.M.7
  • 20
    • 62749167015 scopus 로고    scopus 로고
    • Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein
    • 2-s2.0-62749167015 10.1128/JVI.01970-08
    • Boutwell C. L., Rowley C. F., Essex M., Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein. Journal of Virology 2009 83 6 2460 2468 2-s2.0-62749167015 10.1128/JVI.01970-08
    • (2009) Journal of Virology , vol.83 , Issue.6 , pp. 2460-2468
    • Boutwell, C.L.1    Rowley, C.F.2    Essex, M.3
  • 25
    • 58549114847 scopus 로고    scopus 로고
    • Substantial envelope-specific CD8 T-cell immunity fails to control siv disease
    • 2-s2.0-58549114847 10.1016/j.virol.2008.11.030
    • Peut V., Kent S. J., Substantial envelope-specific CD8 T-cell immunity fails to control siv disease. Virology 2009 384 1 21 27 2-s2.0-58549114847 10.1016/j.virol.2008.11.030
    • (2009) Virology , vol.384 , Issue.1 , pp. 21-27
    • Peut, V.1    Kent, S.J.2
  • 26
    • 36349023857 scopus 로고    scopus 로고
    • Utility of human immunodeficiency virus type 1 envelope as a T-cell immunogen
    • DOI 10.1128/JVI.01408-07
    • Peut V., Kent S. J., Utility of human immunodeficiency virus type 1 envelope as a T-cell immunogen. Journal of Virology 2007 81 23 13125 13134 2-s2.0-36349023857 10.1128/JVI.01408-07 (Pubitemid 350156951)
    • (2007) Journal of Virology , vol.81 , Issue.23 , pp. 13125-13134
    • Peut, V.1    Kent, S.J.2
  • 28
    • 70449719019 scopus 로고    scopus 로고
    • P09-19 LB. CTL escape mutations in gag epitopes restricted by protective HLA class i alleles cause substantial reductions in viral replication capacity
    • ARTICLE 1742 2-s2.0-70449719019 10.1186/1742-4690-6-S3-P399
    • Boutwell C. L., Schneidewind A., Brumme Z., Brockman M., Streeck H., Brumme C., Dudek T., Kane K., Kemper M., Walker B., Altfeld M., Allen T., P09-19 LB. CTL escape mutations in gag epitopes restricted by protective HLA class I alleles cause substantial reductions in viral replication capacity. Retrovirology 2009 6 3, article 1742 P399 2-s2.0-70449719019 10.1186/1742-4690-6-S3-P399
    • (2009) Retrovirology , vol.6 , Issue.3
    • Boutwell, C.L.1    Schneidewind, A.2    Brumme, Z.3    Brockman, M.4    Streeck, H.5    Brumme, C.6    Dudek, T.7    Kane, K.8    Kemper, M.9    Walker, B.10    Altfeld, M.11    Allen, T.12
  • 33
    • 58149398654 scopus 로고    scopus 로고
    • HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1
    • 2-s2.0-58149398654 10.1128/JVI.01471-08
    • Miura T., Brockman M. A., Brumme Z. L., Brumme C. J., Pereyra F., Trocha A., Block B. L., Schneidewind A., Allen T. M., Heckerman D., Walker B. D., HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1. Journal of Virology 2009 83 1 140 149 2-s2.0-58149398654 10.1128/JVI.01471-08
    • (2009) Journal of Virology , vol.83 , Issue.1 , pp. 140-149
    • Miura, T.1    Brockman, M.A.2    Brumme, Z.L.3    Brumme, C.J.4    Pereyra, F.5    Trocha, A.6    Block, B.L.7    Schneidewind, A.8    Allen, T.M.9    Heckerman, D.10    Walker, B.D.11
  • 37
    • 2542493991 scopus 로고    scopus 로고
    • Role of neutralizing antibodies in HIV infection
    • 2-s2.0-2542493991
    • Haigwood N. L., Stamatatos L., Role of neutralizing antibodies in HIV infection. AIDS 2003 17 supplement S67 S71 2-s2.0-2542493991
    • (2003) AIDS , vol.17 , Issue.SUPPL.
    • Haigwood, N.L.1    Stamatatos, L.2
  • 38
    • 0000604395 scopus 로고    scopus 로고
    • The neutralizing antibody response to HIV-1: Viral evasion and escape from humoral immunity
    • s2.0-0000604395
    • Parren P. W., Moore J. P., Burton D. R., Sattentau Q. J., The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity. AIDS 1999 13 supplement S137 162 2-s2.0-0000604395
    • (1999) AIDS , vol.13 , Issue.SUPPL.2
    • Parren, P.W.1    Moore, J.P.2    Burton, D.R.3    Sattentau, Q.J.4
  • 40
    • 0033951746 scopus 로고    scopus 로고
    • Protection of macaques against vaginal transmission of a pathogenic HIV- 1/SIV chimeric virus by passive infusion of neutralizing antibodies
    • DOI 10.1038/72318
    • Mascola J. R., Stiegler G., Vancott T. C., Katinger H., Carpenter C. B., Hanson C. E., Beary H., Hayes D., Frankel S. S., Birx D. L., Lewis M. G., Protection of macaques against vaginal transmission of a pathogenic HIV- 1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nature Medicine 2000 6 2 207 210 2-s2.0-0033951746 10.1038/72318 (Pubitemid 30082367)
    • (2000) Nature Medicine , vol.6 , Issue.2 , pp. 207-210
    • Mascola, J.R.1    Stiegler, G.2    Vancott, T.C.3    Katinger, H.4    Carpenter, C.B.5    Hanson, C.E.6    Beary, H.7    Hayes, D.8    Frankel, S.S.9    Birx, D.L.10    Lewis, M.G.11
  • 43
    • 2442689092 scopus 로고    scopus 로고
    • Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies
    • DOI 10.1128/JVI.78.11.5983-5995.2004
    • Haigwood N. L., Montefiori D. C., Sutton W. F., McClure J., Watson A. J., Voss G., Hirsch V. M., Richardson B. A., Letvin N. L., Hu S. L., Johnson P. R., Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies. Journal of Virology 2004 78 11 5983 5995 2-s2.0-2442689092 10.1128/JVI.78.11.5983-5995.2004 (Pubitemid 38661686)
    • (2004) Journal of Virology , vol.78 , Issue.11 , pp. 5983-5995
    • Haigwood, N.L.1    Montefiori, D.C.2    Sutton, W.F.3    McClure, J.4    Watson, A.J.5    Voss, G.6    Hirsch, V.M.7    Richardson, B.A.8    Letvin, N.L.9    Hu, S.-L.10    Johnson, P.R.11
  • 44
    • 0034864776 scopus 로고    scopus 로고
    • Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
    • DOI 10.1128/JVI.75.17.8340-8347.2001
    • Parren P. W. H. I., Marx P. A., Hessell A. J., Luckay A., Harouse J., Cheng-Mayer C., Moore J. P., Burton D. R., Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. Journal of Virology 2001 75 17 8340 8347 2-s2.0-0034864776 10.1128/JVI.75.17.8340-8347.2001 (Pubitemid 32743706)
    • (2001) Journal of Virology , vol.75 , Issue.17 , pp. 8340-8347
    • Parren, P.W.H.I.1    Marx, P.A.2    Hessell, A.J.3    Luckay, A.4    Harouse, J.5    Cheng-Mayer, C.6    Moore, J.P.7    Burton, D.R.8
  • 45
    • 0033119374 scopus 로고    scopus 로고
    • Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo
    • DOI 10.1016/S1074-7613(00)80043-6
    • Poignard P., Sabbe R., Picchio G. R., Wang M., Gulizia R. J., Katinger H., Parren P. W. H. I., Mosier D. E., Burton D. R., Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. Immunity 1999 10 4 431 438 2-s2.0-0033119374 10.1016/S1074-7613(00)80043-6 (Pubitemid 29205479)
    • (1999) Immunity , vol.10 , Issue.4 , pp. 431-438
    • Poignard, P.1    Sabbe, R.2    Picchio, G.R.3    Wang, M.4    Gulizia, R.J.5    Katinger, H.6    Parren, P.W.H.I.7    Mosier, D.E.8    Burton, D.R.9
  • 46
    • 0031449456 scopus 로고    scopus 로고
    • Passive immunization with a human monoclonal antibody protects hu-PBL- SCID mice against challenge by primary isolates of HIV-1
    • DOI 10.1038/nm1297-1389
    • Gauduin M. C., Parren P. W. H. I., Weir R., Barbas C. F., Burton D. R., Koup R. A., Passive immunization with a human monoclonal antibody protects hu-PBL- SCID mice against challenge by primary isolates of HIV-1. Nature Medicine 1997 3 12 1389 1393 2-s2.0-0031449456 10.1038/nm1297-1389 (Pubitemid 28011040)
    • (1997) Nature Medicine , vol.3 , Issue.12 , pp. 1389-1393
    • Gauduin, M.-C.1    Parren, P.W.H.I.2    Weir, R.3    Barbas, C.F.4    Burton, D.R.5    Koup, R.A.6
  • 47
    • 0030901363 scopus 로고    scopus 로고
    • Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals
    • Moog C., Fleury H. J. A., Pellegrin I., Kirn A., Aubertin A. M., Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals. Journal of Virology 1997 71 5 3734 3741 2-s2.0-0030901363 (Pubitemid 27172386)
    • (1997) Journal of Virology , vol.71 , Issue.5 , pp. 3734-3741
    • Moog, C.1    Fleury, H.J.A.2    Pellegrin, I.3    Kirn, A.4    Aubertin, A.M.5
  • 48
    • 0032210842 scopus 로고    scopus 로고
    • Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120
    • DOI 10.1016/S0264-410X(98)00182-0, PII S0264410X98001820
    • Pinter A., Honnen W. J., Kayman S. C., Trochev O., Wu Z., Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120. Vaccine 1998 16 19 1803 1811 2-s2.0-0032210842 10.1016/S0264-410X(98)00182-0 (Pubitemid 28473919)
    • (1998) Vaccine , vol.16 , Issue.19 , pp. 1803-1811
    • Pinter, A.1    Honnen, W.J.2    Kayman, S.C.3    Trochev, O.4    Wu, Z.5
  • 49
    • 0028847578 scopus 로고
    • Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection
    • 2-s2.0-0028847578 10.1056/NEJM199501263320401
    • Cao Y., Qin L., Zhang L., Safrit J., Ho D. D., Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. New England Journal of Medicine 1995 332 4 201 208 2-s2.0-0028847578 10.1056/NEJM199501263320401
    • (1995) New England Journal of Medicine , vol.332 , Issue.4 , pp. 201-208
    • Cao, Y.1    Qin, L.2    Zhang, L.3    Safrit, J.4    Ho, D.D.5
  • 50
    • 0032505017 scopus 로고    scopus 로고
    • Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection
    • DOI 10.1097/00002030-199813000-00005
    • + T-cell counts and T-cell function in long-term AIDS-free infection. AIDS 1998 12 13 1591 1600 2-s2.0-0032505017 10.1097/00002030-199813000-00005 (Pubitemid 28418328)
    • (1998) AIDS , vol.12 , Issue.13 , pp. 1591-1600
    • Carotenuto, P.1    Looij, D.2    Keldermans, L.3    De Wolf, F.4    Goudsmit, J.5
  • 53
    • 0030856310 scopus 로고    scopus 로고
    • Augmented serum neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates in two groups of HIV-1- infected long-term nonprogressors
    • Zhang Y. J., Fracasso C., Fiore J. R., Björndal Å.., Angarano G., Gringeri A., Fenyö E. M., Augmented serum neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates in two groups of HIV-1- infected long-term nonprogressors. Journal of Infectious Diseases 1997 176 5 1180 1187 2-s2.0-0030856310 (Pubitemid 27460982)
    • (1997) Journal of Infectious Diseases , vol.176 , Issue.5 , pp. 1180-1187
    • Zhang, Y.-J.1    Fracasso, C.2    Fiore, J.R.3    Bjorndal, A.4    Angarano, G.5    Gringeri, A.6    Fenyo, E.M.7
  • 58
    • 40349092000 scopus 로고    scopus 로고
    • Post-infection immunodeficiency virus control by neutralizing antibodies
    • 2-s2.0-40349092000
    • Yamamoto H., Kawada M., Takeda A., Igarashi H., Matano T., Post-infection immunodeficiency virus control by neutralizing antibodies. PloS One 2007 2 6 e540 2-s2.0-40349092000
    • (2007) PloS One , vol.2 , Issue.6
    • Yamamoto, H.1    Kawada, M.2    Takeda, A.3    Igarashi, H.4    Matano, T.5
  • 60
    • 73949154006 scopus 로고    scopus 로고
    • Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L
    • 2-s2.0-73949154006 10.1128/JVI.01272-09
    • Hessell A. J., Rakasz E. G., Tehrani D. M., Huber M., Weisgrau K. L., Landucci G., Forthal D. N., Koff W. C., Poignard P., Watkins D. I., Burton D. R., Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L. Journal of Virology 2010 84 3 1302 1313 2-s2.0-73949154006 10.1128/JVI.01272-09
    • (2010) Journal of Virology , vol.84 , Issue.3 , pp. 1302-1313
    • Hessell, A.J.1    Rakasz, E.G.2    Tehrani, D.M.3    Huber, M.4    Weisgrau, K.L.5    Landucci, G.6    Forthal, D.N.7    Koff, W.C.8    Poignard, P.9    Watkins, D.I.10    Burton, D.R.11
  • 62
    • 77957336593 scopus 로고    scopus 로고
    • Multiple tandem copies of conserved gp41 epitopes incorporated in gag virus-like particles elicit systemic and mucosal antibodies in an optimized heterologous vector delivery regimen
    • 2-s2.0-77957336593 10.1016/j.vaccine.2010.08.009
    • Jain S., Patrick A. J., Rosenthal K. L., Multiple tandem copies of conserved gp41 epitopes incorporated in gag virus-like particles elicit systemic and mucosal antibodies in an optimized heterologous vector delivery regimen. Vaccine 2010 28 43 7070 7080 2-s2.0-77957336593 10.1016/j.vaccine.2010.08.009
    • (2010) Vaccine , vol.28 , Issue.43 , pp. 7070-7080
    • Jain, S.1    Patrick, A.J.2    Rosenthal, K.L.3
  • 63
    • 0031022818 scopus 로고    scopus 로고
    • A novel antibody-dependent cellular cytotoxicity epitope in gp120 is identified by two monoclonal antibodies isolated from a long-term survivor of human immunodeficiency virus type 1 infection
    • Alsmadi O., Herz R., Murphy E., Pinter A., Tilley S. A., A novel antibody-dependent cellular cytotoxicity epitope in gp120 is identified by two monoclonal antibodies isolated from a long-term survivor of human immunodeficiency virus type 1 infection. Journal of Virology 1997 71 2 925 933 2-s2.0-0031022818 (Pubitemid 27030262)
    • (1997) Journal of Virology , vol.71 , Issue.2 , pp. 925-933
    • Alsmadi, O.1    Herz, R.2    Murphy, E.3    Pinter, A.4    Tilley, S.A.5
  • 64
    • 0026042547 scopus 로고
    • Antibody-dependent cell-mediated cytotoxicity directed by a human monoclonal antibody reactive with gp120 of HIV-1
    • 2-s2.0-0026042547
    • Koup R. A., Robinson J. E., Nguyen Q. V., Pikora C. A., Blais B., Roskey A., Panicali D., Sullivan J. L., Antibody-dependent cell-mediated cytotoxicity directed by a human monoclonal antibody reactive with gp120 of HIV-1. AIDS 1991 5 11 1309 1314 2-s2.0-0026042547
    • (1991) AIDS , vol.5 , Issue.11 , pp. 1309-1314
    • Koup, R.A.1    Robinson, J.E.2    Nguyen, Q.V.3    Pikora, C.A.4    Blais, B.5    Roskey, A.6    Panicali, D.7    Sullivan, J.L.8
  • 65
    • 0031974863 scopus 로고    scopus 로고
    • Antibody-dependent cellular cytotoxicity directed against cells expressing human immunodeficiency virus type 1 envelope of primary or laboratory-adapted strains by human and chimpanzee monoclonal antibodies of different epitope specificities
    • Alsmadi O., Tilley S. A., Antibody-dependent cellular cytotoxicity directed against cells expressing human immunodeficiency virus type 1 envelope of primary or laboratory-adapted strains by human and chimpanzee monoclonal antibodies of different epitope specificities. Journal of Virology 1998 72 1 286 293 2-s2.0-0031974863 (Pubitemid 28048839)
    • (1998) Journal of Virology , vol.72 , Issue.1 , pp. 286-293
    • Alsmadi, O.1    Tilley, S.A.2
  • 68
    • 0027056456 scopus 로고
    • Antibody-dependent cellular cytotoxicity (ADCC) is directed against immunodominant epitopes of the envelope proteins of human immunodeficiency virus 1 (HIV-1)
    • Ziegner U. H. M., Frank I., Bernatowicz A., Starr S. E., Streckert H. J., Antibody-dependent cellular cytotoxicity (ADCC) is directed against immunodominant epitopes of the envelope proteins of human immunodeficiency virus 1 (HIV-1). Viral Immunology 1992 5 4 273 281 2-s2.0-0027056456 (Pubitemid 23054089)
    • (1992) Viral Immunology , vol.5 , Issue.4 , pp. 273-281
    • Ziegner, U.H.M.1    Frank, I.2    Bernatowicz, A.3    Starr, S.E.4    Streckert, H.-J.5
  • 69
    • 42449151639 scopus 로고    scopus 로고
    • A bispecific antibody composed of a nonneutralizing antibody to the gp41 immunodominant region and an anti-CD89 antibody directs broad human immunodeficiency virus destruction by neutrophils
    • DOI 10.1128/JVI.02499-07
    • Duval M., Posner M. R., Cavacini L. A., A bispecific antibody composed of a nonneutralizing antibody to the gp41 immunodominant region and an anti-CD89 antibody directs broad human immunodeficiency virus destruction by neutrophils. Journal of Virology 2008 82 9 4671 4674 2-s2.0-42449151639 10.1128/JVI.02499-07 (Pubitemid 351563705)
    • (2008) Journal of Virology , vol.82 , Issue.9 , pp. 4671-4674
    • Duval, M.1    Posner, M.R.2    Cavacini, L.A.3
  • 70
    • 65449179917 scopus 로고    scopus 로고
    • Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines
    • 2-s2.0-65449179917 10.4049/jimmunol.0803115
    • Florese R. H., Demberg T., Xiao P., Kuller L., Larsen K., Summers L. E., Venzon D., Cafaro A., Ensoli B., Robert-Guroff M., Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines. Journal of Immunology 2009 182 6 3718 3727 2-s2.0-65449179917 10.4049/jimmunol.0803115
    • (2009) Journal of Immunology , vol.182 , Issue.6 , pp. 3718-3727
    • Florese, R.H.1    Demberg, T.2    Xiao, P.3    Kuller, L.4    Larsen, K.5    Summers, L.E.6    Venzon, D.7    Cafaro, A.8    Ensoli, B.9    Robert-Guroff, M.10
  • 71
    • 0033587525 scopus 로고    scopus 로고
    • Expression of a novel Nef epitope on the surface of HIV type 1-infected cells
    • DOI 10.1089/088922299310511
    • Yamada T., Iwamoto A., Expression of a novel Nef epitope on the surface of HIV type 1-infected cells. AIDS Research and Human Retroviruses 1999 15 11 1001 1009 2-s2.0-0033587525 10.1089/088922299310511 (Pubitemid 29350670)
    • (1999) AIDS Research and Human Retroviruses , vol.15 , Issue.11 , pp. 1001-1009
    • Yamada, T.1    Iwamoto, A.2
  • 72
    • 0842278637 scopus 로고    scopus 로고
    • Antibody-Dependent Cellular Cytotoxicity via Humoral Immune Epitope of Nef Protein Expressed on Cell Surface
    • Yamada T., Watanabe N., Nakamura T., Iwamoto A., Antibody-dependent cellular cytotoxicity via humoral immune epitope of nef protein expressed on cell surface. Journal of Immunology 2004 172 4 2401 2406 2-s2.0-0842278637 (Pubitemid 38182389)
    • (2004) Journal of Immunology , vol.172 , Issue.4 , pp. 2401-2406
    • Yamada, T.1    Watanabe, N.2    Nakamura, T.3    Iwamoto, A.4
  • 75
    • 79952535555 scopus 로고    scopus 로고
    • Pol as a target for antibody dependent cellular cytotoxicity responses in HIV-1 infection
    • 10.1016/j.virol.2010.12.044
    • Isitman G., Chung A. W., Navis M., Kent S. J., skent@unimelb.edu.au Stratov I., Pol as a target for antibody dependent cellular cytotoxicity responses in HIV-1 infection. Virology 2011 412 1 110 116 10.1016/j.virol.2010. 12.044
    • (2011) Virology , vol.412 , Issue.1 , pp. 110-116
    • Isitman, G.1    Chung, A.W.2    Navis, M.3    Kent, S.J.4    Stratov, I.5
  • 76
    • 43949145619 scopus 로고    scopus 로고
    • Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects
    • DOI 10.1128/JVI.01952-07
    • Stratov I., Chung A., Kent S. J., Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects. Journal of Virology 2008 82 11 5450 5459 2-s2.0-43949145619 10.1128/JVI.01952-07 (Pubitemid 351705252)
    • (2008) Journal of Virology , vol.82 , Issue.11 , pp. 5450-5459
    • Stratov, I.1    Chung, A.2    Kent, S.J.3
  • 80
    • 58549114847 scopus 로고    scopus 로고
    • Substantial envelope-specific CD8 T-cell immunity fails to control siv disease
    • 2-s2.0-58549114847 10.1016/j.virol.2008.11.030
    • Peut V., Kent S. J., Substantial envelope-specific CD8 T-cell immunity fails to control siv disease. Virology 2009 384 1 21 27 2-s2.0-58549114847 10.1016/j.virol.2008.11.030
    • (2009) Virology , vol.384 , Issue.1 , pp. 21-27
    • Peut, V.1    Kent, S.J.2
  • 82
    • 42449102990 scopus 로고    scopus 로고
    • Up on the tightrope: Natural killer cell activation and inhibition
    • DOI 10.1038/ni1581, PII NI1581
    • Lanier L. L., Up on the tightrope: natural killer cell activation and inhibition. Nature Immunology 2008 9 5 495 502 2-s2.0-42449102990 10.1038/ni1581 (Pubitemid 351560518)
    • (2008) Nature Immunology , vol.9 , Issue.5 , pp. 495-502
    • Lanier, L.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.